Showing results (101-110 of 4,554) with videos related to
Sort By:
Pageof 456
Neuropsychiatric Disease and Treatment|September 13, 2017
Erratum: Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy [Corrigendum]Neuropsychiatric Disease and Treatment|March 26, 2016
Association between sociodemographic characteristics and anxiety levels of violence-exposed patients admitted to emergency clinicHilal Hocagil, Filiz Izci, Abdullah Cüneyt Hocagil, et al.Neuropsychiatric Disease and Treatment|March 30, 2016
Brain oscillations in bipolar disorder and lithium-induced changesMurat İlhan AtagünNeuropsychiatric Disease and Treatment|April 26, 2016
Relationship between quality of life and restless legs syndrome among a community-dwelling population in JapanKazutoshi Kubo, Norio Sugawara, Ayako Kaneda, et al.Neuropsychiatric Disease and Treatment|April 26, 2016
The influence of childhood abuse, adult life events, and affective temperaments on the well-being of the general, nonclinical adult populationYoshiaki Kanai, Yoshikazu Takaesu, Yukiei Nakai, et al.Neuropsychiatric Disease and Treatment|May 5, 2016
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI studyLin Wu, Yue Zhang, Fuqing Zhou, et al.Neuropsychiatric Disease and Treatment|May 5, 2016
Shen-Qi-Jie-Yu-Fang exerts effects on a rat model of postpartum depression by regulating inflammatory cytokines and CD4(+)CD25(+) regulatory T cellsJingya Li, Ruizhen Zhao, Xiaoli Li, et al.Neuropsychiatric Disease and Treatment|May 5, 2016
Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi ArabiaFahad D Alosaimi, Abdulhadi Alhabbad, Mohammed F Abalhassan, et al.Neuropsychiatric Disease and Treatment|May 5, 2016
Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People's Republic of ChinaLing Zhang, Yun Chen, Li Yue, et al.Neuropsychiatric Disease and Treatment|December 8, 2015
Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three casesAynur Pekcanlar Akay, Gamze Capa Kaya, Burak Baykara, et al.Pageof 456